Skyland Analytics’ CEO, Bob Di Scipio, Provides Insight on the Challenge of Data Integrity between Sponsors and CDMOs

Dan Schell, Editorial Director | Life Science Leader | How To Avoid Data-Integrity Woes In Pharma | November 1, 2019   Among the multitude of risks that pharma and biotech executives sweat over every day, those related to data integrity have risen to the top of the list in recent years.

Read Full Article